ICL Group (NYSE: ICL) executive reports major stock options

Rhea-AI Filing Summary

ICL Group Ltd. executive Yaniv Kabalek, President, Industrial Products, reported his initial beneficial ownership of stock options on Ordinary Shares. He holds options over 348,928 underlying shares at an exercise price of $8.33 per share, expiring on February 14, 2028. He also holds options over 627,793 underlying shares at an exercise price of $5.87 per share, expiring on April 4, 2029. Some options are fully vested and exercisable, while others vest in three equal annual installments from the April 4, 2024 grant date, and are held by a trustee in his name.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Kabalek Yaniv

Role President, Industrial Products

Type	Security	Shares	Price	Value
holding	Stock Options (Right to Buy)	--	--	--
holding	Stock Options (Right to Buy)	--	--	--

Holdings After Transaction: Stock Options (Right to Buy) — 348,928 shares (Direct)

Footnotes (1)

1. The stock options are fully vested and exercisable. The stock options vest in three equal annual installments from the April 4, 2024, grant date. Represents an exercise price of NIS 26.22, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026. The options are held by a Trustee in the name of the Reporting Person. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

Key Figures

Underlying shares (grant 1): 348,928 shares Exercise price (grant 1): $8.33 per share Expiration date (grant 1): February 14, 2028 +3 more

6 metrics

Underlying shares (grant 1) 348,928 shares Ordinary Shares underlying stock options at $8.33 exercise price

Exercise price (grant 1) $8.33 per share Stock options expiring February 14, 2028

Expiration date (grant 1) February 14, 2028 Directly held stock options on Ordinary Shares

Underlying shares (grant 2) 627,793 shares Ordinary Shares underlying stock options at $5.87 exercise price

Exercise price (grant 2) $5.87 per share Stock options expiring April 4, 2029

Expiration date (grant 2) April 4, 2029 Directly held stock options on Ordinary Shares

Key Terms

Stock Options (Right to Buy), Ordinary Shares, exercise price, fully vested and exercisable, +2 more

6 terms

Stock Options (Right to Buy) financial

"The filing lists derivative holdings as Stock Options (Right to Buy) over Ordinary Shares."

Ordinary Shares financial

"Each option grant references an underlying security title of Ordinary Shares."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"The options have an exercise price of $8.33 and $5.87 per share."

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested and exercisable financial

"One footnote states that the stock options are fully vested and exercisable."

vest in three equal annual installments financial

"Another footnote explains the options vest in three equal annual installments."

Trustee financial

"A footnote notes the options are held by a Trustee in the name of the Reporting Person."

A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kabalek Yaniv

(Last) (First) (Middle)

C/O ICL GROUP LTD.

MILLENNIUM TOWER, 23 ARENHA ST.

(Street)

TEL AVIV 6120201

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ICL Group Ltd. [ ICL ]

3a. Foreign Trading Symbol
[ICL]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Industrial Products

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(1)	02/14/2028	Ordinary Shares	348,928	$8.33(3)	D(4)
Stock Options (Right to Buy)	(2)	04/04/2029	Ordinary Shares	627,793	$5.87(5)	D(4)

Explanation of Responses:

1. The stock options are fully vested and exercisable.

2. The stock options vest in three equal annual installments from the April 4, 2024, grant date.

3. Represents an exercise price of NIS 26.22, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

4. The options are held by a Trustee in the name of the Reporting Person.

5. Represents an exercise price of NIS 18.47, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.149 as of March 27, 2026.

	/s/ Kabalek Yaniv	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Yaniv Kabalek’s Form 3 for ICL show?

The Form 3 shows that Yaniv Kabalek, President, Industrial Products of ICL Group Ltd., holds significant stock options on the company’s Ordinary Shares. It establishes his initial beneficial ownership position rather than reporting any new purchase or sale transactions.

How many ICL options does Yaniv Kabalek report holding?

Yaniv Kabalek reports stock options over 348,928 underlying Ordinary Shares at one exercise price and 627,793 underlying Ordinary Shares at another. These figures reflect his derivative holdings as disclosed in the Form 3, not direct share ownership transactions.

What are the exercise prices of Yaniv Kabalek’s ICL stock options?

The disclosed stock options carry exercise prices of $8.33 per share and $5.87 per share. These exercise prices were derived from Israeli shekel amounts using a Bank of Israel representative exchange rate noted in the Form 3 footnotes.

When do Yaniv Kabalek’s reported ICL stock options expire?

The Form 3 shows one option grant expiring on February 14, 2028, and another expiring on April 4, 2029. These expiration dates define how long Kabalek can exercise the respective stock options on ICL’s Ordinary Shares.

How do Yaniv Kabalek’s ICL stock options vest?

According to the footnotes, some of Kabalek’s ICL stock options are fully vested and exercisable. Another grant vests in three equal annual installments starting from the April 4, 2024 grant date, reflecting a time-based vesting schedule.

Who holds the ICL stock options reported by Yaniv Kabalek?

The Form 3 notes that certain ICL stock options are held by a Trustee in the name of the Reporting Person. This means the options are maintained in trust on behalf of Yaniv Kabalek, while he remains the beneficial owner.